Decision: Favourable

Study Title:

A Phase IIIb, Multicenter, Randomized, Visual Assessor-Masked Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration (DIAGRID)

  • NREC Code:


  • Decision:


  • Study Type:

    CT application

  • Principal Investigator:

    Mr Mark Cahill

  • PI Institution:

    Royal Victoria Eye and Ear Hospital

  • Sponsor:


Scroll to Top